Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using casitone agar and solidified RPMI 1640 medium with 2% glucose

Journal of Clinical Microbiology

Volumn 34, Issue 4, 1996, Pages 848-852

  Espinel Ingroff, A ^a   Pfaller, M ^b   Erwin, M E ^b   Jones, R N ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; GLUCOSE; ITRACONAZOLE; KETOCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; REPRODUCIBILITY; TORULOPSIS GLABRATA; YEAST;

EID: 0029990128     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.4.848-852.1996     Document Type: Article

References (35)

1. AB Biudisk. 1993 Etesl technical guide No. 4 antifungal susceptibility testing of yeasts. AB Biodisk, Solna, Sweden.
2. Anaissie, E. J., G. P. Bodey, and M. G. Rinaldi. 1989. Emerging fungal pathogens. Eur. J. Clin. Microbiol Infect. Dis. 8:323-330.
3. Anaissie, E., V. Paetznick, and G. P. Bodey. 1991. Fluconazole susceptibility testing of Candida albicans. microtiter method that is independent of inoculum size, temperature, and time of reading Antimicrob. Agents Chemother. 35:1641-1646.
4. Beck-Sagué, C. M., W. R. Jarvis, and the National Nosocomial Infections Surveillance System. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990 J. Infect. Dis. 167:1247-1251.
5. Block, E. R, A. E. Jennings, and J. E. Bennett. 1973. 5-Fluorocytosine resistance in Cryptococcus neaformans. Antimicrob. Agents Chemother. 3:647-656.
6. Brass, C., J. Z. Shainhouse, and D. A. Stevens. 1979. Variability of agar dilution-replicator method of yeast susceptibility testing. Antimicrob. Agents Chemother. 15:763-768.
7. Colombo, A. L., F. Barchiesi, D. A. McGough, and M. G. Rinaldi. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole susceptibility testing. J. Clin. Microbiol. 33:535-540
8. Dupont, B., J. R. Graybill, D. Armstrong, R. Laroche, J. E. Touze, and L. J. Wheat. 1992. Fungal infections in AIDS patients. J. Med Vet. Mycol. 30(Suppl. 1):19-28.
9. Espinel-Ingroff, A. 1994. Etest for antifungal susceptibility testing of yeasts. Diagn. Microbiol. Infect. Dis 19:217-220.
10. Espmel-Ingroff, A., K. Dawsun, M. Pfaller, E. Anaissie, B. Breslin, D. Dixon, A. Fothergill, J. Peter, M. Rinaldi, and T. Walsh. 1995. Comparative and collaborative evaluation of standardization antifungal susceptibility testing for filamentous fungi. Antimicrob. Agents Chemother. 39:314-319.
11. Espinel-Ingroff, A., T. M. Kerkering, P. R. Goldson, and S. Shadomy. 1991. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 29:1089-1094.
12. Espinel-Ingroff, A., C. W. Kish, Jr., T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Gerarden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests J. Clin Microbiol. 30:3138-3145.
13. Espinel-Ingroff, A., and M. A. Pfaller. 1995. Antifungal agents and susceptibility testing, p. 1405-1421. In P. K. Murray, E J. Baron, M. A. Pfalier, F. C. Tenover, and R. H. Yolken (ed.). Manual of clinical microbiology, 6th ed American Society for Microbiology, Washington, D.C.
14. Espinel-Ingroff, A., J, L. Rodríguez-Tudela, and J. V. Martíncz-Suárez. 1995 Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution test M27-P for in vitro testing of fluconzole-resistant and -susceptible isolates ol Candida albicans. J. Clin. Microbiol. 33:3154-3158.
15. Espinel-Ingroff, A., L. Steele-Moore, and J. N. Galgiani. 1994. Evaluation of 80% inhibition standards for the determination of fluconazole MICs in three laboratories. Diagn. Microbiol. Infect. Dis. 20:81-86.
16. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993 Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
17. Galgiani, J. N., J. Reiser, C. Brass, A. Espinel-Ingroff, M. A. Gordon, and T. M. Kerkering. 1987. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob. Agents Chemother. 35:1641-1646.
18. Ghannoum, M. A., A. S. Ibrahim, Y. Fu, M. C. Shafiq, J. E. Edwards, and R. S. Criddle. 1992. Susceptibility testing of Cryptococcus neoformans: a microdilution technique J Clin. Microbiol. 30:2881-2886.
19. Keye, J. D., and W. E. Magce. 1956. Fungal diseases in a general hospital Am. J Clin. Pathol. 26:1235-1253.
20. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing for yeasts. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
21. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing for yeasts. Tentative standard M27-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
22. Paya, C. V. 1993 Fungal infections in solid-organ transplant. Clin. Infect. Dis. 16:677-688
23. Pfaller, M. A., M. Bale, B. Buschelman, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, M. G. Rinaldi, C, R. Cooper, and M. R. McGinnis. 1995. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotencin B. fluconazole, and flucytosine. J. Clin. Microbiol. 33:1104-1107.
24. Pfaller, M. A., and A. L. Barry. 1994 Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1992-1996.
25. Pfaller, M. A., S. A. Messer, and S. Coffmann. 1995. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution method to test five antifungal agents including the new triazole DO870. J. Clin. Microbiol. 33:1094-1097
26. Pfaller, M. A., M. G. Rinaldi, J. N. Galgiani, M. S. Bartlett, B. A. Body, A. Espinel-Ingroff, R. A. Fromtling, G. S. Hall, C. E. Hughes, F. C. Odds, and A. M. Sugar. 1990. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob. Agents Chemother 34:1648-1654.
27. Polak, A., and H. J. Scholer. 1975. Mode of action of 5-fluorocytosine and mechanisms of resistance Chemotherapy (Basel) 21:113-130.
28. Redding, S., J. Smith, G. Farinacci, M. Rinaldi, A. Fothergill, J. RhineChalberg, and M. Pfaller. 1994. Development of resistance to fluconazole by Candida albicans during treatment of oropharyngeal candidiasis in AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis Clin. Infect. Dis. 18:240-242.
29. Rex, J. H., C. R. Cooper, Jr., W. G. Merz, J. N. Galgiani, and E. J. Anaissie. 1995 Detection of amphotencin B-resistant Candida species in a brothbased system. Antimicrob. Agents Chemother. 39:906-909.
30. Rodríguez-Tudela, J. L., and J. Martínez-Suárez, 1994 Improved medium for fluconazole susceptibility testing of Candida albicans. Antimicrob. Agents Chemother. 38:45-48.
31. Sewell, D. L., M. A. Pfaller, and A. L. Barry. 1994. Comparison of broth macrodilution, broth microdilution, and E-test antifungal susceptibility tests for fiuconazofe J. Clin Microbiol 32:2099-2102
32. Torack. R. M. 1957. Fungus infections associated with antibiotic and steroid therapy Am. J. Med. 22:872-882.
33. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1988. Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch. Intern. Med. 148:2642-2645
34. Wingard, J. R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect. Dis. 20:115-125.
35. Zimmerman, L. E. 1950. Candida and Aspergillts endocarditis Arch Pathol 50:591-605.